{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:30:42Z","timestamp":1793021442885,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.redox.2023.103010","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T12:14:36Z","timestamp":1703679276000},"page":"103010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress"],"prefix":"10.1016","volume":"69","author":[{"given":"Weijuan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunying","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1180-148X","authenticated-orcid":false,"given":"Liang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2023.103010_bib1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/01.RES.0000207406.94146.c2","article-title":"Diabetic cardiomyopathy: the search for a unifying hypothesis","volume":"98","author":"Poornima","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.103010_bib2","doi-asserted-by":"crossref","first-page":"H1060","DOI":"10.1152\/ajpheart.00646.2012","article-title":"Ketone body metabolism and cardiovascular disease","volume":"304","author":"Cotter","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.redox.2023.103010_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.molcel.2015.05.037","article-title":"Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling","volume":"59","author":"Kang","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.redox.2023.103010_bib4","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71270","article-title":"beta-hydroxybutyrate accumulates in the rat heart during low-flow ischaemia with implications for functional recovery","volume":"10","author":"Lindsay","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.redox.2023.103010_bib5","doi-asserted-by":"crossref","first-page":"E287","DOI":"10.1152\/ajpendo.00308.2010","article-title":"Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes","volume":"300","author":"Zhang","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2023.103010_bib6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2337\/db13-1090","article-title":"Regulation of hypothalamic neuronal sensing and food intake by ketone bodies and fatty acids","volume":"63","author":"Le Foll","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2023.103010_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.5650\/jos.ess16069","article-title":"Lauric acid stimulates ketone body production in the KT-5 astrocyte cell line","volume":"65","author":"Nonaka","year":"2016","journal-title":"J. Oleo Sci."},{"key":"10.1016\/j.redox.2023.103010_bib8","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.molmet.2016.07.011","article-title":"Knockdown of ATP citrate lyase in pancreatic beta cells does not inhibit insulin secretion or glucose flux and implicates the acetoacetate pathway in insulin secretion","volume":"5","author":"El Azzouny","year":"2016","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2023.103010_bib9","doi-asserted-by":"crossref","first-page":"20570","DOI":"10.1074\/jbc.M114.565457","article-title":"The retinal pigment epithelium utilizes fatty acids for ketogenesis","volume":"289","author":"Adijanto","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.103010_bib10","doi-asserted-by":"crossref","first-page":"11417","DOI":"10.1080\/21655979.2022.2063222","article-title":"HMGCS2 silencing attenuates high glucose-induced in vitro diabetic cardiomyopathy by increasing cell viability, and inhibiting apoptosis, inflammation, and oxidative stress","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.redox.2023.103010_bib11","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41598-017-04469-z","article-title":"HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk","volume":"7","author":"Shukla","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2023.103010_bib12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2018.07.006","article-title":"Empagliflozin increases cardiac energy production in diabetes: novel translational insights into the heart failure benefits of SGLT2 inhibitors","volume":"3","author":"Verma","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.redox.2023.103010_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013039","article-title":"Increased glucose availability attenuates myocardial ketone body utilization","volume":"9","author":"Brahma","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.redox.2023.103010_bib14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.molmet.2014.07.010","article-title":"Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling","volume":"3","author":"Schugar","year":"2014","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.redox.2023.103010_bib15","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.103010_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.121.056824","article-title":"Effect of empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial","volume":"144","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2023.103010_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(21)00292-8","article-title":"Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial","volume":"10","author":"Verma","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.redox.2023.103010_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.103010_bib19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cardfail.2020.04.005","article-title":"Myocardial ketones metabolism in heart failure","volume":"26","author":"Karwi","year":"2020","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.redox.2023.103010_bib20","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2023.103010_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.redox.2023.103010_bib22","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.103010_bib23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Investigators, Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2023.103010_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/FJC.0000000000000608","article-title":"Irisin protects heart against ischemia-reperfusion injury through a SOD2-dependent mitochondria mechanism","volume":"72","author":"Wang","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.redox.2023.103010_bib25","doi-asserted-by":"crossref","first-page":"24447","DOI":"10.1074\/jbc.M110.100651","article-title":"Adaptation of myocardial substrate metabolism to a ketogenic nutrient environment","volume":"285","author":"Wentz","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2023.103010_bib26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0748730414543141","article-title":"Cardiomyocyte-specific BMAL1 plays critical roles in metabolism, signaling, and maintenance of contractile function of the heart","volume":"29","author":"Young","year":"2014","journal-title":"J. Biol. Rhythm."},{"key":"10.1016\/j.redox.2023.103010_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/CIRCRESAHA.116.303356","article-title":"Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress","volume":"116","author":"Ikeda","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2023.103010_bib28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.redox.2023.103010_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2017.07.003","article-title":"The role of OXCT1 in the pathogenesis of cancer as a rate-limiting enzyme of ketone body metabolism","volume":"183","author":"Zhang","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2023.103010_bib30","first-page":"4","article-title":"The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense","author":"Horton","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.redox.2023.103010_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101395","article-title":"Ketone bodies, stress response, and redox homeostasis","volume":"29","author":"Rojas-Morales","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2023.103010_bib32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4070\/kcj.2019.0180","article-title":"Cardioprotective potential of an SGLT2 inhibitor against doxorubicin-induced heart failure","volume":"49","author":"Oh","year":"2019","journal-title":"Korean Circ J"},{"key":"10.1016\/j.redox.2023.103010_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2018.04.019","article-title":"Treatment with D-beta-hydroxybutyrate protects heart from ischemia\/reperfusion injury in mice","volume":"829","author":"Yu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2023.103010_bib34","doi-asserted-by":"crossref","first-page":"H751","DOI":"10.1152\/ajpheart.00260.2021","article-title":"Why the diabetic heart is energy inefficient: a ketogenesis and ketolysis perspective","volume":"321","author":"Mishra","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.redox.2023.103010_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.metabol.2017.08.005","article-title":"The diabetic heart utilizes ketone bodies as an energy source","volume":"77","author":"Mizuno","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.redox.2023.103010_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2015.04.056","article-title":"Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease","volume":"763","author":"Ong","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2023.103010_bib37","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)\/H(+) exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.redox.2023.103010_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41569-022-00824-4","article-title":"SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism","volume":"20","author":"Packer","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.redox.2023.103010_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-014-0148-1","article-title":"Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice","volume":"13","author":"Lin","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.redox.2023.103010_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1042\/CS20190585","article-title":"Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice","volume":"133","author":"Xue","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.redox.2023.103010_bib41","doi-asserted-by":"crossref","first-page":"E1119","DOI":"10.1152\/ajpendo.00047.2011","article-title":"A defect in Nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes","volume":"301","author":"Bitar","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2023.103010_bib42","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1073\/pnas.85.11.4046","article-title":"Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues","volume":"85","author":"Zweier","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2023.103010_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2023.102200","article-title":"Effect of SGLT2 inhibitor on cardiomyopathy in a rat model of T2DM: possible involvement of cardiac aquaporins","volume":"85","author":"Eltobshy","year":"2023","journal-title":"Tissue Cell"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723004111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231723004111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T03:46:44Z","timestamp":1729482404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231723004111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":43,"alternative-id":["S2213231723004111"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2023.103010","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin improves mitochondrial dysfunction in diabetic cardiomyopathy by modulating ketone body metabolism and oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2023.103010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103010"}}